Alternative limb-lengthening technique makes recovery process less cumbersome A highly specialized process that lengthens bones can avoid the need for amputations in selected individuals who have suffered serious fractures. And now a new study has discovered that an alternative solution limb-lengthening technique makes the lengthy recovery process much less cumbersome – – while still offering good-to-superb outcomes. Loyola University INFIRMARY orthopaedic surgeon Mitchell Bernstein, MD, is usually first author of the scholarly study, published in the journal Clinical Orthopaedics and Related Study.Posadas, MD, medical director of the Urologic Oncology Program at the Samuel Oschin Comprehensive Tumor Institute and the lead investigator of the new study. The Cedars-Sinai scientific trial calls for up to 40 adult patients who’ll all receive cabozantinib. During the first three cycles, patients will be evaluated two times per month so that doctors can adjust dosages. Participants will undergo imaging tests every two months to monitor their cancers. Patients can continue treatment for as long as a benefit has been received by them. The FDA-approved clinical trial will allow physicians and researchers to spotlight a blood – and tissue-based evaluation of disease markers which will provide insight into how cabozantinib works in sufferers with this specific kind of cancer and various other cancers as well.

CREST: Carotid artery surgery and stenting possess long-term outcomes for individuals with stroke Physicians will have two effective and safe options to treat their patients in risk for stroke, says a researcher at Mayo Clinic who led a large, NIH-funded, national scientific trial testing use or surgery of a stent to open a blocked carotid artery.